17.05.2010 • NewsHexionQ1 2010

Hexion Specialty Chemicals Posts Q1 Loss

Privately held Hexion Specialty Chemicals posted a first-quarter loss, though revenue and demand for its products jumped.

The company reported a net loss of $7 million compared with net income of $117 million for the same period last year, which included a large gain from early debt repayment. Revenue rose 28 percent to $1.17 billion, while volume rose 25%.

"We remain optimistic that the gradual recovery in volumes will continue in 2010," Chief Executive Craig O. Morrison said. "However, we believe the extent of the economic recovery is likely to vary significantly by industry sector and geographical region."

Hexion is owned by Apollo Management LP, a private equity firm that also owns the Harrah's casino chain and Norwegian Cruise Lines.

Company

Hexion Specialty Chemicals

Gennaerstr. 2-4
58642 Iserlohn
Germany

Company contact







Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.